GRETA SLAPPY: Open Payments
NPI 1447644265 · SYLVESTER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 21 payments from 10 companies in 2025. Trend: 2023 $508 · 2024 $394 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $96 |
| Sumitomo Pharma America, Inc. | 1 | $84 |
| Lilly USA, LLC | 4 | $70 |
| Novo Nordisk Inc | 3 | $59 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| PFIZER INC. | 2 | $41 |
| Bard Peripheral Vascular, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $21 |
| Amgen Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
Products named: GEMTESA, MOUNJARO, TRELEGY ELLIPTA, ELIQUIS, UBRELVY, VRAYLAR, RotarexS 6 F x 135 cm, JARDIANCE.
Industry payments across GA — which companies pay providers there.
